» Articles » PMID: 17192540

Human Trypanosoma Evansi Infection Linked to a Lack of Apolipoprotein L-I

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2006 Dec 29
PMID 17192540
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Humans have innate immunity against Trypanosoma brucei brucei that is known to involve apolipoprotein L-I (APOL1). Recently, a case of T. evansi infection in a human was identified in India. We investigated whether the APOL1 pathway was involved in this occurrence. The serum of the infected patient was found to have no trypanolytic activity, and the finding was linked to the lack of APOL1, which was due to frameshift mutations in both APOL1 alleles. Trypanolytic activity was restored by the addition of recombinant APOL1. The lack of APOL1 explained the patient's infection with T. evansi.

Citing Articles

Apolipoprotein-L Functions in Membrane Remodeling.

Pays E Cells. 2025; 13(24.

PMID: 39768205 PMC: 11726835. DOI: 10.3390/cells13242115.


Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease.

Zimmerman B, Dakin L, Fortier A, Nanou E, Blasio A, Mann J Nat Commun. 2025; 16(1):167.

PMID: 39747090 PMC: 11696124. DOI: 10.1038/s41467-024-55408-2.


Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease.

Pays E Cells. 2024; 13(20.

PMID: 39451256 PMC: 11506758. DOI: 10.3390/cells13201738.


Parasitological and molecular investigation of Trypanosoma evansi in dromedaries from Greater Cairo, Egypt.

Amer M, Soliman A, Do T, Hegab A, El-Kelesh E, Li Y J Vet Med Sci. 2024; 86(11):1177-1184.

PMID: 39358244 PMC: 11569872. DOI: 10.1292/jvms.24-0284.


The Janus-faced functions of Apolipoproteins L in membrane dynamics.

Pays E Cell Mol Life Sci. 2024; 81(1):134.

PMID: 38478101 PMC: 10937811. DOI: 10.1007/s00018-024-05180-9.